[HTML][HTML] A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - Springer
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - europepmc.org
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - research.rug.nl
Background: Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - search.proquest.com
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
A Multicentre, Patient-and Assessor-blinded, Non-inferiority, Randomised and Controlled Phase Ii Trial to Compare Standard and Torque Teno Virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - 2023 - researchsquare.com
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
[HTML][HTML] A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - ncbi.nlm.nih.gov
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas… - Trials, 2023 - pubmed.ncbi.nlm.nih.gov
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
[HTML][HTML] A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas… - …, 2023 - trialsjournal.biomedcentral.com
Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus
trough level, which cannot sufficiently predict allograft rejection and infection. The plasma …
trough level, which cannot sufficiently predict allograft rejection and infection. The plasma …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - 2023 - digital.csic.es
[Methods] For this purpose, a randomised, controlled, interventional, two-arm, non-inferiority,
patient-and assessor-blinded, investigator-driven phase II trial was designed. A total of 260 …
patient-and assessor-blinded, investigator-driven phase II trial was designed. A total of 260 …
A multicentre, patient-and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided …
F Haupenthal, J Rahn, F Maggi, F Gelas, P Bourgeois… - Trials, 2023 - europepmc.org
Background Immunosuppression after kidney transplantation is mainly guided via plasma
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …
tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The …